Literature DB >> 33843946

Evaluation of Time-Limited Trials Among Critically Ill Patients With Advanced Medical Illnesses and Reduction of Nonbeneficial ICU Treatments.

Dong W Chang1,2, Thanh H Neville3, Jennifer Parrish1, Lian Ewing2,4, Christy Rico5, Liliacna Jara5, Danielle Sim6, Chi-Hong Tseng6, Carin van Zyl7, Aaron D Storms7, Nader Kamangar2,4, Janice M Liebler5, May M Lee5, Hal F Yee2.   

Abstract

Importance: For critically ill patients with advanced medical illnesses and poor prognoses, overuse of invasive intensive care unit (ICU) treatments may prolong suffering without benefit. Objective: To examine whether use of time-limited trials (TLTs) as the default care-planning approach for critically ill patients with advanced medical illnesses was associated with decreased duration and intensity of nonbeneficial ICU care. Design, Setting, and Participants: This prospective quality improvement study was conducted from June 1, 2017, to December 31, 2019, at the medical ICUs of 3 academic public hospitals in California. Patients at risk for nonbeneficial ICU treatments due to advanced medical illnesses were identified using categories from the Society of Critical Care Medicine guidelines for admission and triage. Interventions: Clinicians were trained to use TLTs as the default communication and care-planning approach in meetings with family and surrogate decision makers. Main Outcomes and Measures: Quality of family meetings (process measure) and ICU length of stay (clinical outcome measure).
Results: A total of 209 patients were included (mean [SD] age, 63.6 [16.3] years; 127 men [60.8%]; 101 Hispanic patients [48.3%]), with 113 patients (54.1%) in the preintervention period and 96 patients (45.9%) in the postintervention period. Formal family meetings increased from 68 of 113 (60.2%) to 92 of 96 (95.8%) patients between the preintervention and postintervention periods (P < .01). Key components of family meetings, such as discussions of risks and benefits of ICU treatments (preintervention, 15 [34.9%] vs postintervention, 56 [94.9%]; P < .01), eliciting values and preferences of patients (20 [46.5%] vs 58 [98.3%]; P < .01), and identifying clinical markers of improvement (9 [20.9%] vs 52 [88.1%]; P < .01), were discussed more frequently after intervention. Median ICU length of stay was significantly reduced between preintervention and postintervention periods (8.7 [interquartile range (IQR), 5.7-18.3] days vs 7.4 [IQR, 5.2-11.5] days; P = .02). Hospital mortality was similar between the preintervention and postintervention periods (66 of 113 [58.4%] vs 56 of 96 [58.3%], respectively; P = .99). Invasive ICU procedures were used less frequently in the postintervention period (eg, mechanical ventilation preintervention, 97 [85.8%] vs postintervention, 70 [72.9%]; P = .02). Conclusions and Relevance: In this study, a quality improvement intervention that trained physicians to communicate and plan ICU care with family members of critically ill patients in the ICU using TLTs was associated with improved quality of family meetings and a reduced intensity and duration of ICU treatments. This study highlights a patient-centered approach for treating critically ill patients that may reduce nonbeneficial ICU care. Trial Registration: ClinicalTrials.gov Identifier: NCT04181294.

Entities:  

Mesh:

Year:  2021        PMID: 33843946      PMCID: PMC8042568          DOI: 10.1001/jamainternmed.2021.1000

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  7 in total

1.  Time-limited trial of intensive care is more than merely life sustaining.

Authors:  Emmanuel Hei-Lok Cheung; Jonathan Chun-Hei Cheung; Yu-Yeung Yip
Journal:  Intensive Care Med       Date:  2022-02-11       Impact factor: 41.787

Review 2.  The Role of Palliative Care in COPD.

Authors:  Anand S Iyer; Donald R Sullivan; Kathleen O Lindell; Lynn F Reinke
Journal:  Chest       Date:  2021-11-03       Impact factor: 10.262

Review 3.  Addressing Futility: A Practical Approach.

Authors:  Piroska K Kopar; Adrienne Visani; Kyler Squirrell; Douglas E Brown
Journal:  Crit Care Explor       Date:  2022-07-01

4.  Raising awareness for time-limited trial discussion upon ICU triage and admission.

Authors:  Emmanuel Hei-Lok Cheung; Jonathan Chun-Hei Cheung; Yu-Yeung Yip
Journal:  Intensive Care Med       Date:  2021-12-01       Impact factor: 41.787

5.  Time-limited trials in the ICU: a mixed-methods sequential explanatory study of intensivists at two academic centres.

Authors:  Elizabeth M Viglianti; Jennifer N Ervin; Chad A Newton; Jacqueline M Kruser; Theodore J Iwashyna; Thomas S Valley
Journal:  BMJ Open       Date:  2022-04-04       Impact factor: 2.692

6.  Utilization and Delivery of Specialty Palliative Care in the ICU: Insights from the Palliative Care Quality Network.

Authors:  Allyson Cook Chapman; Joseph A Lin; Julien Cobert; Angela Marks; Jessica Lin; David L O'Riordan; Steven Z Pantilat
Journal:  J Pain Symptom Manage       Date:  2022-06       Impact factor: 5.576

7.  Code status transitions in patients with high-risk acute myeloid leukemia.

Authors:  Hannah R Abrams; Ryan D Nipp; Lara Traeger; Mitchell W Lavoie; Matthew J Reynolds; Nneka N Ufere; Annie C Wang; Kofi Boateng; Thomas W LeBlanc; Areej El-Jawahri
Journal:  Blood Adv       Date:  2022-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.